Achieve Life Sciences, Inc. - Common Shares
$100,000.00 invested would be worth $152,813.67 (+52.8%) · Full backtester →
Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
No fundamental data is currently available for this listing from our data providers.
Educational technical indicators — not investment advice. TradeOrgs does not place trades.
Sentiment is a keyword-based read of the headline — a rough signal, not advice.